Is AstraZeneca (azn) a good stock to buy?

Digging into valuation, Astrazeneca currently has a Forward P/E ratio of 19.3. This represents a premium compared to its industry's average Forward P/E of 14.19. Meanwhile, AZN's PEG ratio is currently 1.4. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate.

Where is AstraZeneca plc headquartered?

AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is Select to analyze similar companies using key performance metrics; select up to 4 stocks.

What happened to AstraZeneca (AZN)?

Astrazeneca (AZN) closed the most recent trading day at $78.99, moving +1.24% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.11%. Elsewhere, the Dow lost 0.3%, while the tech-heavy Nasdaq added 0.56%. Coming into today, shares of the pharmaceutical had gained 2.19% in the past month.